Ahn M. H., Kang C. M., Park C. S., Park S. J., Rhim T., Yoon P. O., Chang H. S., Kim S. H., Kyono H., and Kim K. C. 2005. Titanium dioxide particle-induced goblet cell hyperplasia: Association with mast cells and IL-13. Respir. Res. 6:34.
Battisto J. R., Smith R. N., Beckman K., Sternlicht M., and Welles W. L. 1982. Susceptibility to adjuvant arthritis in DA and F344 rats. A dominant trait controlled by an autosomal gene locus linked to the major histocompatibility complex. Arthritis Rheum. 25:1194–1200.
Bermudez E., Mangum J. B., Wong B. A., Asgharian B., Hext P. M., Warheit D. B., and Everitt J. I. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 77:347–357.
Cambi A., and Figdor C. G. 2003. Dual function of C-type lectin- like receptors in the immune system. Curr. Opin. Cell Biol. 15:539–546.
Dieu M. C., Vanbervliet B., Vicari A., Bridon J. M., Oldham E., Aït- Yahia S., Brière F., Zlotnik A., Lebecque S., and Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373–386.
Dimitrijevic M., Laban O., Djuric V. J., Stanojevic S., Miletic T., Kovacevic-Jovanovic V., Todorovic C., and Radulovic J. 2001. Behavior and severity of adjuvant arthritis in four rat strains. Brain Behav. Immun. 15:255–265.
Eishi Y., and McCullagh P. 1988. PVG rats, resistant to experimental allergic thyroiditis, develop high serum levels of thyroglobulin after sensitization. Clin. Immunol. Immunopathol. 49:101–106.
Gasser D. L., Newlin C. M., Palm J., and Gonatas N. K. 1973. Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science. 181:872–873.
Geijtenbeek T. B., van Vliet S. J., Engering A., ‘t Hart B. A., and van Kooyk Y. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22:33–54.
Griffiths M. M., Eichwald E. J., Martin J. H., Smith C. B., and DeWitt C. W. 1981. Immunogenetic control of experimental Type II collagen- induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 24:781–789.
Gurr J. R., Wang A. S., Chen C. H., and Jan K. Y. 2005. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213:66–73.
Hussain S., Boland S., Baeza-Squiban A., Hamel R., Thomassen L. C., Martens J. A., Billon-Galland M. A., Fleury-Feith J., Moisan F., Pairon J. C., and Marano F. 2009. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: Role of particle surface area and internalized amount. Toxicology 260:142–149.
Kelly F. J., and Sandström T. 2004. Air pollution, oxidative stress, and allergic response. Lancet 363:95–96.
Kheradmand T., Trivedi P. P., Wolf N. A., Roberts P. C., and Swanborg R. H. 2008. Characterization of a subset of bone marrow-derived natural killer cells that regulates T-cell activation in rats. J. Leukoc. Biol. 83:1128–1135.
Kobayashi N., Naya M., Endoh S., Maru J., Yamamoto K., and Nakanishi J. 2009. Comparative pulmonary toxicity study of nano-TiO particles 2 of different sizes and agglomerations in rats: different short- and long-term post-instillation results. Toxicology 264:110–118.
Lambrecht B. N., Carro-Muino I., Vermaelen K., and Pauwels R. A. 1999. Allergen-induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats. Am. J. Respir. Cell Mol. Biol. 20:1165–1174.
Lampinen M., Carlson M., Håkansson L. D., and Venge P. 2004. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59:793–805.
Larsen S. T., Roursgaard M., Jensen K. A., and Nielsen G. D. 2010. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin. Pharmacol. Toxicol. 106:114–117.
Li N., Xia T., and Nel A. E. 2008. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic. Biol. Med. 44:1689–1699.
Lorentzen J. C., Andersson M., Issazadeh S., Dahlman I., Luthman H., Weissert R., and Olsson T. 1997. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats. J. Neuroimmunol. 80:31–37.
Lorentzen J. C., Flornes L., Eklöw C., Bäckdahl L., Ribbhammar U., Guo J. P., Smolnikova M., Dissen E., Seddighzadeh M., Brookes A. J., Alfredsson L., Klareskog L., Padyukov L., and Fossum S. 2007. Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum. 56:2620–2632.
Lundqvist M., Nygren P., Jonsson B. H., and Broo K. 2006. Induction of structure and function in a designed peptide upon adsorption on a silica nanoparticle. Angew. Chem. Int. Ed. Engl. 45:8169–8173.
Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., and Dawson K. A. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 105:14265–14270.
Ma-Hock L., Burkhardt S., Strauss V., Gamer A. O., Wiench K., van Ravenzwaay B., and Landsiedel R. 2009. Development of a short- term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol. 21:102–118.
MacNee W., and Donaldson K. 2003. Mechanism of lung injury caused by PM and ultrafine particles with special reference to COPD. Eur. 10 Respir. J. Suppl. 40:47s–51s.
Maitre B., Boussat S., Jean D., Gouge M., Brochard L., Housset B., Adnot S., and Delclaux C. 2001. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur. Respir. J. 18:100–106.
Mills, K. H. 2008. Induction, function, and regulation of IL-17- producing T cells. Eur. J. Immunol. 38:2636–2649.
Mills N. L., Törnqvist H., Gonzalez M. C., Vink E., Robinson S. D., Söderberg S., Boon N. A., Donaldson K., Sandström T., Blomberg A., and Newby D. E. 2007. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. New Engl. J. Med. 357:1075–1082.
Nakagawa H., Komorita N., Shibata F., Ikesue A., Konishi K., Fujioka M., and Kato H. 1994. Identification of cytokine-induced neutrophil chemoattractants (CINC), rat GRO/CINC-2 α and CINC-2 β, produced by granulation tissue in culture: Purification, complete amino acid sequences, and characterization. Biochem. J. 301 (Pt 2):545–550.
Nel A., Xia T., Mädler L., and Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–627.
NIOSH. 2005. NIOSH Current Intelligence Bulletin: Evaluation of Health Hazard and Recommendations for Occupational Exposure to Titanium Dioxide. Public Review Draft, November 2005. Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health.
Oberdörster G., Ferin J., Gelein R., Soderholm S. C., and Finkelstein J. 1992. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ. Health Perspect. 97:193–199.
Oberdörster G., Ferin J., and Lehnert B. E. 1994. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102 (Suppl 5):173–179.
Park E. J., Yoon J., Choi K., Yi J., and Park K. 2009. Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology 260:37–46.
Renwick L. C., Brown D., Clouter A., and Donaldson K. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup. Environ. Med. 61:442–447.
Sager T. M., Kommineni C., and Castranova V. 2008. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: Role of particle surface area. Part. Fibre Toxicol. 5:17.
Sayes C. M., Wahi R., Kurian P. A., Liu Y., West J. L., Ausman K. D., Warheit D. B., and Colvin V. L. 2006. Correlating nanoscale titania structure with toxicity: A cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci. 92:174–185.
Singh S., Shi T., Duffin R., Albrecht C., van Berlo D., Höhr D., Fubini B., Martra G., Fenoglio I., Borm P. J., and Schins R. P. 2007. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO : Role 2 of the specific surface area and of surface methylation of the particles. Toxicol. Appl. Pharmacol. 222:141–151.
Törnqvist H., Mills N. L., Gonzalez M., Miller M. R., Robinson S. D., Megson I. L., Macnee W., Donaldson K., Söderberg S., Newby D. E., Sandström T., and Blomberg A. 2007. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am. J. Respir. Crit. Care Med. 176:395–400.
Warheit D. B., Hansen J. F., Yuen I. S., Kelly D. P., Snajdr S. I., and Hartsky M. A. 1997. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol. Appl. Pharmacol. 145:10–22.
Warheit D. B., Webb T. R., Reed K. L., Frerichs S., and Sayes C. M. 2007. Pulmonary toxicity study in rats with three forms of ultrafine-TiO 2 particles: differential responses related to surface properties. Toxicology 230:90–104.
Warheit D. B., Webb T. R., Sayes C. M., Colvin V. L., and Reed K. L. 2006. Pulmonary instillation studies with nanoscale TiO rods 2 and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol. Sci. 91:227–236.